木瓜直播

A from Spectranetics is being recalled due to a risk of a blocked guidewire lumen preventing balloon utilization, according to an FDA MedWatch report. Using this device may result in incorrect positioning and uncontrolled hemorrhaging.

A study of consecutive patients with inoperable chronic thromboembolic pulmonary hypertension showed improved hemodynamics and exercise capacity after , with effects lasting more than 3 years. There was a 14% rate of hemoptysis, which the investigators called "acceptable." (European Heart Journal)

Oversizing drug-eluting stents may be beneficial in , according to a study showing greater stent expansion and less incomplete stent apposition without an uptick in arterial wall injury. Researchers advocated the "aggressive selection of larger stents, with appropriate attention to edge effects," in this population. (Circulation: Cardiovascular Interventions)

can be treated successfully with endovascular therapy, as observed in a case report published in Vascular and Endovascular Surgery. Operators performed afferent vessel embolization and percutaneous thrombin injection into the nidus to exclude the malformation.

A one-step procedure takes care of pre-stenting and implantation of the . This simplified procedure resulted in lower dose area products and radiation times, according to a database series in Catheterization and Cardiovascular Interventions.

The Resonate family of cardiac implantable electronic devices featuring the HeartLogic Heart Failure Diagnostic won FDA approval for . Implanted patients can receive full-body MRI scans in 1.5 Tesla environments. (MedGadget)

TVA Medical's -- a 4-French catheter system with enhanced visual indicators that creates an arteriovenous fistula for hemodialysis - got the European CE Mark, the manufacturer announced. The 6-French system had already received European and Canadian regulatory clearance for use with end-stage renal disease patients who need hemodialysis. (PR Newswire)

Comment